A5050793947- Cancer-related molecular mechanisms research
- Irrigation Practices and Water Management
- Gut microbiota and health
- RNA modifications and cancer
- Circular RNAs in diseases
- Probiotics and Fermented Foods
- Tree Root and Stability Studies
- Mycobacterium research and diagnosis
- Digestive system and related health
- Colorectal Cancer Screening and Detection
- Nanoplatforms for cancer theranostics
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Plant Surface Properties and Treatments
- Cancer Research and Treatments
- Cancer Cells and Metastasis
Northern Jiangsu People's Hospital
2024
Yangzhou University
2023
Abstract Presenting with a poor prognosis, gastric cancer (GC) remains one of the leading causes disease and death worldwide. Long non-coding RNAs (lncRNAs) regulate tumor formation have been long used to predict prognosis. N7-methylguanosine (m7G) is most prevalent RNA modification. m7G-lncRNAs GC onset progression, but their precise mechanism in unclear. The objective this research was development new m7G-related lncRNA signature as biomarker for predicting survival rate guiding treatment....
Background: Gut microbiota are associated with the pathological features and development of colorectal cancer (CRC); however, how gut changes in patients CRC is unknown. This study investigated role progression by retrospectively comparing structural differences between healthy individuals. Methods: Together clinical data, we collected fecal samples from (n = 18) controls performed 16S rRNA gene sequencing alpha beta diversity analysis to compare richness diversity. Based on control groups,...
Abstract Presenting with a poor prognosis, gastric cancer (GC) remains one of the leading causes disease and death worldwide. Long non-coding RNAs (lncRNAs) regulate tumor formation have been long used to predict prognosis. N7-methylguanosine (m7G) is most prevalent RNA modification. m7G-linked lncRNAs GC onset progression, but their precise mechanism in unclear. The objective this research was development new lncRNA signature as biomarker for predicting survival rate guiding treatment....